Testosterone is the principal androgenic steroid hormone synthesized primarily in testicular Leydig cells (95%) and adrenal cortex (5%), regulating male sexual differentiation, reproductive function, muscle anabolism, bone density, and exerting sex-specific immunomodulation by generally suppressing antibody production and Th2 responses while promoting Th1 cellular immunity.
Think of testosterone as the foreman of a construction crew who walks around the job site actively suppressing the "clean-up and repair team" (antibody-producing B cells and Th2 cells) while encouraging the "demolition squad" (Th1 cells and cellular immunity). When the foreman is present, the construction site runs lean and aggressiveβheavy machinery operates (muscle building), structural work proceeds (bone formation), and the focus is on active defense (killing infected cells) rather than perimeter security (making antibodies).
When Prolactin shows upβthink of it as the site inspector during family leaveβthe foreman (testosterone) is told to step aside. Now the clean-up crew (antibody production, Th2) takes over, which is exactly what you want when caring for an infant: strong antibody transfer through Breastmilk, reduced aggression, increased nurturing behavior. The construction site becomes a nursery. The trade-off? Lower muscle mass, reduced libido, slightly more inflammation, and higher risk of infection (the price of being a present parent).
This explains why men have lower rates of autoimmune disease (the foreman keeps the antibody-overproduction crew in check) but higher mortality from infections (sometimes you need antibodies, not just cell-mediated killing). It also explains why low testosterone in aging or chronic illness correlates with increased inflammationβwhen the foreman leaves, the site gets chaotic.
Cholesterol β Pregnenolone (via CYP11A1) β Progesterone β 17-hydroxyprogesterone (via CYP17A1) β androstenedione β testosterone (via 17Ξ²-HSD3 in testes).
- Genomic pathway: Testosterone binds intracellular androgen receptor (AR) β AR dissociates from heat shock proteins β AR dimerizes β translocates to nucleus β binds androgen response elements (AREs) on DNA β transcription of target genes (myosin heavy chain, IGF-1 receptor, type I collagen)
- Non-genomic pathway: Membrane-associated ARs activate MAPK/ERK, PI3K/Akt, and PKC pathways within seconds-to-minutes (relevant for rapid behavioral and vascular effects)
- 5Ξ±-reductase converts testosterone β dihydrotestosterone (DHT, 2-5Γ more potent, dominant in prostate, skin, hair follicles)
- Aromatase converts testosterone β estradiol (critical in bone, brain, and adipose tissue; explains why testosterone supports bone density partly through estrogen signaling)
graph TD
T[Testosterone] -->|Binds AR| Th1[Promotes Th1 differentiation]
T -->|Suppresses| IL4[IL-4 production]
T -->|Suppresses| IL6[IL-6 from macrophages]
T -->|Reduces| BCells[B cell antibody production]
T -->|Inhibits| NFkB["NF-ΞΊB activation"]
Th1 --> IFNg["IFN-Ξ³ β"]
IL4 --> Th2["Th2 responses β"]
IL6 --> Inflammation["Systemic inflammation β"]
BCells --> Antibodies["IgG/IgM β"]
NFkB --> Cytokines["Pro-inflammatory cytokines β"]
Prolactin["Prolactin β"] -->|Suppresses| T
Prolactin --> Th2Shift[Th2 shift]
Prolactin --> AbProduction["Antibody production β"]
Specific mechanisms:
- Testosterone inhibits IL-6 production from macrophages via AR-mediated suppression of NF-ΞΊB translocation
- Promotes Th1 by upregulating T-bet transcription factor and IFN-Ξ³ production
- Suppresses Th2 by inhibiting GATA-3 and IL-4 secretion
- Reduces B cells antibody synthesis by downregulating CD40L expression on T cells (blocks T-B cell co-stimulation)
- Inhibits IL-1Ξ² and TNF-Ξ± secretion from activated monocytes
Prolactin β binds prolactin receptors on Leydig cells β inhibits GnRH pulsatility at hypothalamus β β LH release β β testosterone synthesis. Chronic elevation (>20 ng/mL in men) causes hypogonadism. This is the evolutionary switch for parental care: high Prolactin during infant care suppresses testosterone, reducing aggression and mating behavior while enhancing nurturing and antibody-mediated infant protection.
Men have 3-10Γ lower incidence of most autoimmune diseases (rheumatoid arthritis, Systemic lupus erythematosus, Hashimoto's thyroiditis, SjΓΆgren's syndrome) compared to women. Mechanism: testosterone's suppression of autoreactive B cells and Th2-mediated tissue damage. Post-menopausal women and men with hypogonadism show converging autoimmune risk profiles, suggesting sex hormone balance is more critical than chromosomal sex.
Exam insight: This explains why rheumatoid arthritis often improves during pregnancy (high Progesterone and Cortisol) but worsens postpartum when testosterone/progesterone drop and Prolactin surges.
Low testosterone (<300 ng/dL in men) is both a cause and consequence of metabolic syndrome:
- Cause: Reduced testosterone β β visceral adiposity (via β lipoprotein lipase inhibition) β adipose tissue secretes IL-6, TNF-Ξ± β insulin resistance β hyperinsulinemia further suppresses testosterone synthesis (vicious cycle)
- Consequence: Chronic inflammation (β IL-6, CRP) directly inhibits Leydig cell steroidogenesis via NF-ΞΊB-mediated mitochondrial dysfunction
Clinical threshold: Testosterone <264 ng/dL strongly predicts Type 2 Diabetes and CVD in longitudinal studies. Free testosterone (bioavailable, not SHBG-bound) is more predictive than total testosterone.
Testosterone modulates serotonin and dopamine synthesis in the prefrontal cortex and Hippocampus. Hypogonadism correlates with:
Testosterone replacement in men with confirmed hypogonadism (<300 ng/dL + symptoms) shows moderate antidepressant effects (NNT ~8 for clinically significant improvement).
Modern testosterone decline (average 1% per year after age 30, accelerated by sedentary behavior, obesity, chronic stress) represents an evolutionary mismatch:
Selfish immune system: Low testosterone β immune system "escapes restraint" β β autoimmunity and inflammation. The immune system's "selfishness" (prioritizing its own activation) is normally checked by gonadal hormones.
-
Address upstream causes before replacement:
-
Nutritional support:
- Zinc (25-50 mg/day, cofactor for 17Ξ²-HSD3)
- Vitamin D (optimal 40-60 ng/mL, upregulates AR expression)
- Magnesium (400 mg/day, β free testosterone by displacing SHBG)
-
Exercise prescription:
- Resistance training (β testosterone 15-20% acutely, sustained with progressive overload)
- Avoid chronic endurance training (β Cortisol, β testosterone)
-
When to refer for replacement:
- Total testosterone <300 ng/dL on two morning measurements (before 10 AM) + symptoms (libido β, fatigue, muscle mass loss)
- Free testosterone <50 pg/mL
- Monitor estradiol (avoid aromatase excess), hematocrit (erythropoiesis risk), PSA (theoretical prostate cancer concern)
- Normal range: 300-1000 ng/dL total testosterone in adult men (10.4-34.7 nmol/L); women 15-70 ng/dL
- Circadian rhythm: Peaks 06:00-08:00 (30% higher than evening), follows pulsatile LH secretion
- Age decline: ~1-2% per year after age 30; accelerates with comorbidities
- 95% testicular, 5% adrenal synthesis in men; women produce ~10% as much, primarily from adrenal DHEA conversion
- Prolactin >20 ng/mL (in men) suppresses testosterone via GnRH inhibition; physiological during paternal care post-infant birth
- Aromatization: 0.2-0.3% of testosterone β estradiol in men; critical for bone health (testosterone alone insufficient)
- DHT conversion: 5-10% of testosterone β DHT via 5Ξ±-reductase; DHT cannot aromatize (explains finasteride side effects)
- Immunosuppression threshold: Testosterone >600 ng/dL associated with maximal Th1/Th2 ratio shift
- Half-life: Free testosterone 10-100 minutes; total (SHBG-bound) ~8 days
- SHBG binding: 60% bound to SHBG, 38% albumin-bound, 2% free (bioavailable); Insulin resistance β SHBG β falsely "normal" total testosterone but low free testosterone
- Prolactin β Directly suppresses testosterone synthesis; evolutionary trade-off between mating effort and parental care
- Cortisol β Competes for cholesterol substrate and steroidogenic enzymes; chronic stress β hypogonadism
- Oestradiol β Aromatized from testosterone; mediates bone and brain effects; excess causes negative feedback
- Th1-Th2 balance β Testosterone promotes Th1 (cell-mediated) while suppressing Th2 (antibody-mediated) immunity
- autoimmune disease β Low testosterone in men or high estrogen in women predicts autoimmune risk
- B cells β Testosterone suppresses antibody production via downregulation of CD40L co-stimulation
- IL-6 β Testosterone inhibits IL-6 secretion from macrophages; low testosterone β chronic IL-6 elevation
- TNF-Ξ± β Suppressed by testosterone via AR-mediated NF-ΞΊB inhibition
- metabolic syndrome β Bidirectional: low testosterone causes insulin resistance, which further lowers testosterone
- insulin resistance β Hyperinsulinemia directly suppresses Leydig cell steroidogenesis
- Depression β Hypogonadism reduces BDNF and neurosteroid synthesis; testosterone replacement shows antidepressant effects
- BDNF β Testosterone upregulates BDNF in hippocampus; low testosterone β impaired neuroplasticity
- muscle mass β Testosterone drives myofibrillar protein synthesis via IGF-1/Akt/mTOR pathway
- bone metabolism β Testosterone β estradiol (via aromatase) β osteoblast activity; pure testosterone insufficient for bone health
- Breastmilk β Prolactin-induced testosterone suppression shifts maternal immunity toward antibody production for passive transfer
- HPA-axis β Chronic cortisol elevation competitively inhibits testosterone synthesis
- adipose tissue β Aromatase in fat converts testosterone β estradiol; obesity β hypogonadism β more obesity
- Vitamin D β Upregulates androgen receptor expression; deficiency associated with lower testosterone
- Zinc β Cofactor for 17Ξ²-HSD3 (final testosterone synthesis step) and 5Ξ±-reductase
- Ashwagandha β Adaptogen shown to increase testosterone 15% in stressed men by reducing cortisol
- chronic inflammation β IL-6 and TNF-Ξ± inhibit Leydig cell function; testosterone suppresses both cytokines (negative feedback loop disrupted in disease)
- Module 1 β Neuroendocrinology and immune system interactions
- Module 8 β HPG-axis and sex hormone regulation